Introduction, rationale, and methodology

被引:3
|
作者
Olson, Jeffrey J. [1 ]
Ryken, Timothy Charles [2 ]
Kalkanis, Steven N. [3 ]
机构
[1] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA
[2] Iowa Spine & Brain Inst, Dept Neurosurg, Waterloo, IA USA
[3] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA
关键词
NEWLY-DIAGNOSED GLIOBLASTOMA; MULTIFORME; GUIDELINES; THERAPIES; TEMOZOLOMIDE; MANAGEMENT; SURVIVAL;
D O I
10.1007/s11060-013-1329-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This series of guidelines was constructed primarily to assess the currently existing evidence for management of progressive glioblastoma in a manner that sets a benchmark for further improvement in this task. Only by designing future investigations in a high quality manner that recognizes and overcomes prior weaknesses and limitations noted in these guidelines will advancement toward a remedy of this disease be achieved. Secondarily, the suggestions provided are set forth for conscientious use by the practicing physician who must take into account all of the unique individual conditions in the guidance of a given patient during his or her illness. The application of published guidelines information is an activity that results in strong and often polarized opinions. The guidelines presented in this current project are not meant to resolve these issues and it is unlikely that any could accomplish such a goal. Fortunately new research is constantly underway and these guidelines are meant to be improved as this new evidence matures and is published. © Springer Science+Business Media 2014.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 50 条
  • [41] Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology
    Lavikainen, Lauri, I
    Guyatt, Gordon H.
    Lee, Yung
    Couban, Rachel J.
    Luomaranta, Anna L.
    Sallinen, Ville J.
    Kalliala, Ilkka E. J.
    Karanicolas, Paul J.
    Cartwright, Rufus
    Aaltonen, Riikka L.
    Ahopelto, Kaisa
    Aro, Karoliina M.
    Beilmann-Lehtonen, Ines
    Blanker, Marco H.
    Cardenas, Jovita L.
    Craigie, Samantha
    Galambosi, Paivi J.
    Garcia-Perdomo, Herney A.
    Ge, Fang Zhou
    Gomaa, Huda A.
    Huang, Linglong
    Izett-Kay, Matthew L.
    Joronen, Kirsi M.
    Karjalainen, Paivi K.
    Khamani, Nadina
    Kilpelainen, Tuomas P.
    Kivela, Antti J.
    Korhonen, Tapio
    Lampela, Hanna
    Mattila, Anne K.
    Najafabadi, Borna Tadayon
    Nykanen, Taina P.
    Nysten, Carolina
    Oksjoki, Sanna M.
    Pandanaboyana, Sanjay
    Pourjamal, Negar
    Ratnayake, Chathura B. B.
    Raudasoja, Aleksi R.
    Singh, Tino
    Tahtinen, Riikka M.
    Vernooij, Robin W. M.
    Wang, Yuting
    Xiao, Yingqi
    Yao, Liang
    Haukka, Jari
    Tikkinen, Kari A. O.
    SYSTEMATIC REVIEWS, 2021, 10 (01)
  • [42] Taiwan Society of Cardiology Heart Failure Registry 2020: Rationale and Design
    Chang, Hung-Yu
    Lee, Chi-Ming
    Hung, Chung-Lieh
    Sung, Shih-Hsien
    Lin, Tsung-Hsien
    Wu, Yen-Wen
    Hwang, Juey-Jen
    Chen, Wen-Jone
    Wang, Chun-Chieh
    ACTA CARDIOLOGICA SINICA, 2024, 40 (02) : 235 - 241
  • [43] Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations
    Sherman, Morris
    Bruix, Jordi
    Porayko, Michael
    Tram Tran
    HEPATOLOGY, 2012, 56 (03) : 793 - 796
  • [44] The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model
    Chakhtoura, M.
    Leslie, W. D.
    McClung, M.
    Cheung, A. M.
    Fuleihan, G. El-Hajj
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (01) : 127 - 137
  • [45] Rationale and design of DanGer shock: Danish-German cardiogenic shock trial
    Udesen, Nanna Junker
    Moller, Jacob Eifer
    Lindholm, Matias Greve
    Eiskjaer, Hans
    Schaefer, Andreas
    Werner, Nikos
    Holmvang, Lene
    Terkelsen, Christian Juhl
    Jensen, Lisette Okkels
    Junker, Anders
    Schmidt, Henrik
    Wachtell, Kristian
    Thiele, Holger
    Engstrom, Thomas
    Hassager, Christian
    AMERICAN HEART JOURNAL, 2019, 214 : 60 - 68
  • [46] Rationale and design of the CardioMEMS Post-Market Multinational Clinical Study: COAST
    Cowie, Martin R.
    de Groote, Pascal
    McKenzie, Scott
    Brett, Marie-Elena
    Adamson, Philip B.
    ESC HEART FAILURE, 2020, 7 (03): : 865 - 872
  • [47] Acute normovolemic hemodilution in cardiac surgery: Rationale and design of a multicenter randomized trial
    Monaco, Fabrizio
    Guarracino, Fabio
    Vendramin, Igor
    Lei, Chong
    Zhang, Hui
    Lomivorotov, Vladimir
    Osinsky, Roman
    Efremov, Sergey
    Gurcu, Mustafa Emre
    Mazzeffi, Michael
    Pasyuga, Vadim
    Kotani, Yuki
    Biondi-Zoccai, Giuseppe
    D'Ascenzo, Fabrizio
    Romagnoli, Enrico
    Neto, Caetano Nigro
    Da Nascimento, Vinicius Tadeu Nogueira
    Do Nascimento, Silva
    Ti, Lian Kah
    Lorsomradee, Suraphong
    Farag, Ahmed
    Bukamal, Nazar
    Brizzi, Giulia
    Lobreglio, Rosetta
    Belletti, Alessandro
    Arangino, Cristina
    Paternoster, Gianluca
    Bonizzoni, Matteo Aldo
    Tucciariello, Maria Teresa
    Kroeller, Daniel
    Prima, Ambra Licia Di
    Mantovani, Lorenzo Filippo
    Ajello, Valentina
    Gerli, Chiara
    Porta, Sabrina
    Ferrod, Federica
    Giardina, Giuseppe
    Santonocito, Cristina
    Ranucci, Marco
    Lembo, Rosalba
    Pisano, Antonio
    Morselli, Federica
    Nakhnoukh, Cristina
    Oriani, Alessandro
    Pieri, Marina
    Scandroglio, Anna Mara
    Kirali, Kaan
    Likhvantsev, Valery
    Longhini, Federico
    Yavorovskiy, Andrey
    CONTEMPORARY CLINICAL TRIALS, 2024, 143
  • [48] Effects of carvedilol on the prevention of cardiotoxicity induced by anthracyclines: Design and rationale of the CARDIOTOX trial
    Costa, Isabela Bispo Santos da Silva
    Furtado, Remo H. M.
    Drager, Luciano F.
    Silva, Pedro Gabriel Melo
    de Melo, Marcelo Dantas Tavares
    Araruna, Paula
    Bacchiega, Bruno C.
    Cauduro, Sanderson
    Walter, Edilson
    Fialho, Guilherme Loureiro
    Silvestre, Odilson
    Damiani, Lucas P.
    Barbosa, Lilian M.
    Nascimento, Mariane
    Silva, Ana Cecilia Alcantara
    de Mattos, Renata Rodrigues
    Saretta, Roberta
    Rehder, Marilia Harumi H. S.
    Hajjar, Ludhmila Abrahao
    Lopes-Fernandez, Teresa
    Dent, Susan
    Gibson, C. Michael
    Lopes, Renato D.
    Kalil Filho, Roberto
    AMERICAN HEART JOURNAL, 2025, 285 : 1 - 11
  • [49] Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial
    Myles, Paul S.
    Richards, Toby
    Klein, Andrew
    Smith, Julian
    Wood, Erica M.
    Heritier, Stephane
    McGiffin, David
    Zavarsek, Silva
    Symons, Joel
    McQuilten, Zoe K.
    Baker, Robert A.
    Karkouti, Keyvan
    Wallace, Sophia
    AMERICAN HEART JOURNAL, 2021, 239 : 64 - 72
  • [50] Rationale and design of the First Brazilian Cardiovascular Registry of Atrial Fibrillation: The RECALL study
    Lopes, Renato D.
    Vicenzo de Paola, Angelo Amato
    Lorga Filho, Adalberto Menezes
    Consolim-Colombo, Fernanda Marciano
    Andrade, Jadelson
    Piva e Mattos, Luiz Alberto
    Bernardez-Pereira, Sabrina
    Berwanger, Otavio
    de Oliveira Figueiredo, Marcio Jansen
    AMERICAN HEART JOURNAL, 2016, 176 : 10 - 16